CareMax (NASDAQ:CMAX – Get Rating) had its price objective cut by investment analysts at Cowen from $11.00 to $8.00 in a note issued to investors on Wednesday, The Fly reports. Cowen’s price objective suggests a potential upside of 102.53% from the company’s current price.
Separately, Zacks Investment Research cut CareMax from a “buy” rating to a “hold” rating in a research report on Monday, January 17th. One research analyst has rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat.com, CareMax has a consensus rating of “Buy” and a consensus target price of $11.85.
NASDAQ CMAX opened at $3.95 on Wednesday. The company’s 50-day moving average is $7.28. CareMax has a fifty-two week low of $3.58 and a fifty-two week high of $16.00. The company has a quick ratio of 4.90, a current ratio of 4.92 and a debt-to-equity ratio of 0.22.
A number of hedge funds have recently bought and sold shares of the stock. Sciencast Management LP acquired a new stake in CareMax in the 1st quarter worth about $228,000. Monolith Advisors acquired a new stake in CareMax in the 4th quarter worth about $38,000. Susquehanna International Group LLP acquired a new stake in CareMax in the 4th quarter worth about $589,000. Marshall Wace LLP acquired a new stake in CareMax in the 4th quarter worth about $38,000. Finally, Millennium Management LLC boosted its holdings in CareMax by 7.4% in the 4th quarter. Millennium Management LLC now owns 1,627,919 shares of the company’s stock worth $12,502,000 after buying an additional 112,182 shares during the last quarter. Institutional investors own 69.18% of the company’s stock.
CareMax Company Profile (Get Rating)
CareMax, Inc provides medical services through physicians and health care professionals. It offers a suite of health care and social services to its patients, including primary care, specialty care, telemedicine, health and wellness, optometry, dental, pharmacy, and transportation. The company also provides CareOptimize, a proprietary software and services platform that provides data, analytics, and rules-based decision tools/workflows for physicians in the United States.
- Get a free copy of the StockNews.com research report on CareMax (CMAX)
- Is Now The Time To Buy Coinbase (NASDAQ: COIN)?
- Inflation Hasn’t Peaked At Reynolds Consumer Products
- Fifth Third Bancorp Stock Bestows Opportunity
- 3 Reasons Why Hostess Brands Could Be a Sweet Addition to Your Watchlist
- XPO Logistics Is A Logical Choice For Investors
Receive News & Ratings for CareMax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CareMax and related companies with MarketBeat.com's FREE daily email newsletter.